The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.
about
TRPV1: on the road to pain reliefEvidence for bladder urothelial pathophysiology in functional bladder disordersUrothelial signaling.Bladder sensory desensitization decreases urinary urgency.TRP channels in lower urinary tract dysfunction.Release of ATP from rat urinary bladder mucosa: role of acid, vanilloids and stretchImmunocytochemical characterisation of cultures of human bladder mucosal cellsNew insights into the pharmacology of the bladderAcid-sensitive ion channels and receptorsNew aspects in the differential diagnosis and therapy of bladder pain syndrome/interstitial cystitisEffect of SQW on the bladder function of mice lacking TRPV1The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensorBladder dysfunction in multiple sclerosis.Augmented bladder urothelial polyamine signaling and block of BK channel in the pathophysiology of overactive bladder syndrome.Functional TRP and ASIC-like channels in cultured urothelial cells from the rat.Transient receptor potential A1 receptor-mediated neural cross-talk and afferent sensitization induced by oxidative stress: implication for the pathogenesis of interstitial cystitis/bladder pain syndrome.Potential Future Pharmacological Treatment of Bladder Dysfunction.The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial.Development of novel and non-invasive diagnostic markers for lower urinary tract symptoms using urothelial cells in voided urine.Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015.Capsaicin-induced rapid neutrophil leukocyte activation in the rat urinary bladder microcirculatory bed.Cross-sensitization mechanisms between colon and bladder via transient receptor potential A1 stimulation in rats.Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells.
P2860
Q24650367-39915C7D-52D0-48C8-985C-DE7D52338214Q26824708-950D013C-14FB-4226-BB6C-E0FFD516EC96Q30440958-4E2C35D3-9EA6-4840-A07F-CA58F301BF57Q30832054-B0A137F4-903B-43FB-89E2-D272CC5F717DQ33562153-1C4E9FED-C470-4D70-A2B5-4E5776A1CFC6Q33569495-E82DE1AC-EC35-4AD8-8584-F6D15D72841FQ33874538-4AFA39CB-9E28-462C-96DD-76F60BD663E6Q34931019-A1D34833-7FAB-4ACB-9BB6-ECB9DEDD0F6CQ35178189-FDAAE193-F40D-489F-AFCC-E428AB4787BBQ35418701-4D22123B-8429-4107-9855-7213EE480001Q36192134-E98DD33E-F885-4FF9-865F-D90F6AE0DCCBQ37023861-180286C7-9633-4A54-929B-CD2EB729F314Q37409485-6CE8C57D-4769-4696-ABB6-D4AD470DFF4AQ37474476-FB724B89-B97C-40F3-AC05-CEAA9A4D2294Q37680912-EDC4F679-3D90-4E6A-A7C7-6EB35D2E727EQ37986932-8A0FA289-4F37-4466-8806-D24D909DFF22Q38779624-684BCCFD-CF40-4BBA-88CE-DD0C18E65B41Q44343810-1F35A353-ED54-4547-AAAB-D98EA910D2F2Q47240171-25750D84-FA3D-44F6-916C-BF17557871C9Q48054557-CF90CC60-D59C-4143-B88C-C4E6CC0F5585Q48314947-6A20F275-34B2-4180-8D27-1B6315577532Q50427008-CE4F5F49-0AB7-40C9-98A1-555E37931D6FQ53265209-2FBDBF9E-0F7E-470F-A536-2650A7EC47DE
P2860
The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The molecular basis of urgency ...... in the human urinary bladder.
@en
The molecular basis of urgency ...... in the human urinary bladder.
@nl
type
label
The molecular basis of urgency ...... in the human urinary bladder.
@en
The molecular basis of urgency ...... in the human urinary bladder.
@nl
prefLabel
The molecular basis of urgency ...... in the human urinary bladder.
@en
The molecular basis of urgency ...... in the human urinary bladder.
@nl
P2093
P356
P1476
The molecular basis of urgency ...... in the human urinary bladder.
@en
P2093
Elizabeth Burcher
Ika Kristiana
Kenneth J Vaux
Richard J Millard
P304
433-8; discussion 439; discussion 451-3
P356
10.1002/NAU.20326
P577
2007-01-01T00:00:00Z